ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,414Medicare Part D Prescriptions Filled, Including Refills

Rank: 30 out of 68

$429K Total Retail Price of All Prescriptions

Rank: 25 out of 68

262 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
89% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Pennsylvania
Lower avg

Schedule Two
Controlled Substances

26% of this provider’s 262 patients filled at least one prescription for a schedule two drug, compared to an average of 11%.

Schedule Three
Controlled Substances

11% of this provider’s 262 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

1% of this provider’s 6,826 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

33% of this provider’s prescriptions were for brand-name drugs, compared to an average of 24%.

Prescription Price

$58 was the average price of a prescription from this provider, compared to $52 among peers.

Prescriptions per Patient

28 is the average number of prescriptions (including refills) per patient, compared to an average of 29.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Pennsylvania
FUROSEMIDE 324 317 1 3
IPRATROPIUM-ALBUTEROL 312 311 2 52
LEVOTHYROXINE SODIUM 271 245 3 2
OMEPRAZOLE 256 243 4 5
POLYETHYLENE GLYCOL 3350 252 251 5 22
DONEPEZIL HCL 210 210 6 10
NAMENDA 197 197 7 16
POTASSIUM CHLORIDE 175 175 8 18
CITALOPRAM HBR 142 142 9 9
METOPROLOL TARTRATE 128 128 10 6
FENTANYL 114 101 S2 11 39
AMLODIPINE BESYLATE 104 96 12 7
MIRTAZAPINE 97 97 13 15
TRAZODONE HCL 84 80 14 32
GABAPENTIN 82 71 15 12
TRAMADOL HCL 79 65 16 23
VENLAFAXINE HCL ER 78 72 17 84
ALBUTEROL SULFATE 76 71 18 77
BUSPIRONE HCL 76 72 18 98
ATENOLOL 74 69 20 21
CARBAMAZEPINE 71 41 21 141
TAMSULOSIN HCL 71 58 21 28
LACTULOSE 71 51 21 127
LISINOPRIL 68 59 24 4
ENOXAPARIN SODIUM 67 55 25 99
JANTOVEN 64 64 26 24
SERTRALINE HCL 63 46 27 20
RISPERIDONE 62 60 28 25
DIGOXIN 62 62 28 45
NYSTOP 61 55 30 106
SIMVASTATIN 59 43 31 1
SULFAMETHOXAZOLE-TRIMETHOPRIM 58 51 32 80
LEVOFLOXACIN 57 50 33 91
LEVEMIR 55 14 34 138
HYDROCODONE-ACETAMINOPHEN 52 47 S3 35 17
ROPINIROLE HCL 52 52 35 119
CLOPIDOGREL 51 43 37 31
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.